Literature DB >> 27252539

Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.

Zhenjian He1,2,3, Xun Zhu2,3,4, Weitao Wen2,3,4, Jie Yuan2,3,5, Yiwen Hu2,3,4, Jiahui Chen2,3,4, Shu An2,3,4, Xinhuai Dong2,3,4, Cuiji Lin2,3,4, Jianchen Yu2,3,4, Jueheng Wu2,3,4, Yi Yang2,6, Junchao Cai2,3,4, Jun Li2,3,5, Mengfeng Li7,3,4.   

Abstract

UNLABELLED: Dengue virus (DENV) is the most common mosquito-borne virus infecting humans and is currently a serious global health challenge. To establish infection in its host cells, DENV must subvert the production and/or antiviral effects of interferon (IFN). The aim of this study was to understand the mechanisms by which DENV suppresses IFN production. We determined that DENV NS4A interacts with mitochondrial antiviral signaling protein (MAVS), which was previously found to activate NF-κB and IFN regulatory factor 3 (IRF3), thus inducing type I IFN in the mitochondrion-associated endoplasmic reticulum membranes (MAMs). We further demonstrated that NS4A is associated with the N-terminal CARD-like (CL) domain and the C-terminal transmembrane (TM) domain of MAVS. This association prevented the binding of MAVS to RIG-I, resulting in the repression of RIG-I-induced IRF3 activation and, consequently, the abrogation of IFN production. Collectively, our findings illustrate a new molecular mechanism by which DENV evades the host immune system and suggest new targets for anti-DENV strategies. IMPORTANCE: Type I interferon (IFN) constitutes the first line of host defense against invading viruses. To successfully establish infection, dengue virus (DENV) must counteract either the production or the function of IFN. The mechanism by which DENV suppresses IFN production is poorly understood and characterized. In this study, we demonstrate that the DENV NS4A protein plays an important role in suppressing interferon production through binding MAVS and disrupting the RIG-I-MAVS interaction in mitochondrion-associated endoplasmic reticulum membranes (MAMs). Our study reveals that MAVS is a novel host target of NS4A and provides a molecular mechanism for DENV evasion of the host innate immune response. These findings have important implications for understanding the pathogenesis of DENV and may provide new insights into using NS4A as a therapeutic and/or prevention target.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27252539      PMCID: PMC4984625          DOI: 10.1128/JVI.00221-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

2.  Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Luis Martínez-Sobrido; Elina I Zúñiga; Debralee Rosario; Adolfo García-Sastre; Juan Carlos de la Torre
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Interactions between the endoplasmic reticulum, mitochondria, plasma membrane and other subcellular organelles.

Authors:  Magdalena Lebiedzinska; György Szabadkai; Aleck W E Jones; Jerzy Duszynski; Mariusz R Wieckowski
Journal:  Int J Biochem Cell Biol       Date:  2009-03-05       Impact factor: 5.085

4.  Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation.

Authors:  Tsung-Hsien Chang; Ching-Len Liao; Yi-Ling Lin
Journal:  Microbes Infect       Date:  2005-08-15       Impact factor: 2.700

5.  Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons.

Authors:  M S Diamond; T G Roberts; D Edgil; B Lu; J Ernst; E Harris
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.

Authors:  Meleri Jones; Andrew Davidson; Linda Hibbert; Petra Gruenwald; Joerg Schlaak; Simon Ball; Graham R Foster; Michael Jacobs
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 7.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Cardif-mediated signaling controls the initial innate response to dengue virus in vivo.

Authors:  Stuart T Perry; Tyler R Prestwood; Steven M Lada; Chris A Benedict; Sujan Shresta
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

9.  MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease.

Authors:  Martin Baril; Marie-Eve Racine; François Penin; Daniel Lamarre
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

10.  Secreted expression and purification of dengue 2 virus full-length nonstructural glycoprotein NS1 in Pichia pastoris.

Authors:  Jun-mei Zhou; Yun-xia Tang; Dan-yun Fang; Jing-jiao Zhou; Yu Liang; Hui-yu Guo; Li-fang Jiang
Journal:  Virus Genes       Date:  2006-08       Impact factor: 2.198

View more
  39 in total

1.  Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells.

Authors:  Jenn-Haung Lai; Mei-Yi Wang; Chuan-Yueh Huang; Chien-Hsiang Wu; Li-Feng Hung; Chia-Ying Yang; Po-Yuan Ke; Shue-Fen Luo; Shih-Jen Liu; Ling-Jun Ho
Journal:  EMBO Rep       Date:  2018-06-07       Impact factor: 8.807

Review 2.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

Review 3.  Collateral Damage during Dengue Virus Infection: Making Sense of DNA by cGAS.

Authors:  Sebastian Aguirre; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

4.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

Review 5.  Antagonism of type I interferon by flaviviruses.

Authors:  Lisa Miorin; Ana M Maestre; Ana Fernandez-Sesma; Adolfo García-Sastre
Journal:  Biochem Biophys Res Commun       Date:  2017-05-31       Impact factor: 3.575

6.  Tembusu Virus Nonstructural Protein 2B Antagonizes Type I Interferon Production by Targeting MAVS for Degradation.

Authors:  Peng Zhou; Yaqian Li; Aixin Liu; Qingxiang Zhang; Wanrong Wu; Hui Jin; Anan Jongkaewwattana; Qigai He; Rui Luo
Journal:  J Virol       Date:  2022-07-11       Impact factor: 6.549

Review 7.  Innate immune receptors drive dengue virus immune activation and disease.

Authors:  Joris Sprokholt; Leanne C Helgers; Teunis Bh Geijtenbeek
Journal:  Future Virol       Date:  2017-11-17       Impact factor: 1.831

Review 8.  Immune Response to Dengue and Zika.

Authors:  Annie Elong Ngono; Sujan Shresta
Journal:  Annu Rev Immunol       Date:  2018-01-18       Impact factor: 28.527

Review 9.  Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments.

Authors:  Katharina S Schulz; Karen L Mossman
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

10.  Zika Virus Disrupts Phospho-TBK1 Localization and Mitosis in Human Neuroepithelial Stem Cells and Radial Glia.

Authors:  Marco Onorati; Zhen Li; Fuchen Liu; André M M Sousa; Naoki Nakagawa; Mingfeng Li; Maria Teresa Dell'Anno; Forrest O Gulden; Sirisha Pochareddy; Andrew T N Tebbenkamp; Wenqi Han; Mihovil Pletikos; Tianliuyun Gao; Ying Zhu; Candace Bichsel; Luis Varela; Klara Szigeti-Buck; Steven Lisgo; Yalan Zhang; Anze Testen; Xiao-Bing Gao; Jernej Mlakar; Mara Popovic; Marie Flamand; Stephen M Strittmatter; Leonard K Kaczmarek; E S Anton; Tamas L Horvath; Brett D Lindenbach; Nenad Sestan
Journal:  Cell Rep       Date:  2016-08-24       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.